“Primum non nocere” (First, do no harm)

Semin Reprod Med 2012; 30(02): 075-076
DOI: 10.1055/s-0032-1307414

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Authors

Richard H. Reindollar

¹Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, New Hampshire
Marlene B. Goldman

¹Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, New Hampshire

References
1 Greenhill JP. Evaluation of salpingostomy and tubal implantation for treatment of sterility. Am J Obstet Gynecol 1937; 33: 39
2 Lunenfeld B, Menzi A, Volet B. Clinical effects of human postmenopausal gonadotropins. Acta Endocrinol (Copenh) 1960; 51: 587
3 Greenblatt RB, Barfield WE, Jungck EC, Ray AW. Induction of ovulation with MRL/41. Preliminary report. JAMA 1961; 178: 101-104
4 Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978; 2 (8085) 366
5 Strain L, Dean JCS, Hamilton MPR, Bonthron DT. A true hermaphrodite chimera resulting from embryo amalgamation after in vitro fertilization. N Engl J Med 1998; 338 (3) 166-169
6 Reindollar RH, Regan MM, Neumann PJ , et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010; 94 (3) 888-899
7 Reindollar RH, Thornton KL, Ryley D, Alper MM, Fung JL, Goldman MB. A randomized clinical trial to determine optimal infertility therapy in couples when the female partner is 38–42 years: preliminary results from the Forty and Over infertility Treatment Trial (FORT-T). Fertil Steril 2011; 96 (3) S1